345 related articles for article (PubMed ID: 23372686)
61. Transcriptional co-activator TAZ sustains proliferation and tumorigenicity of neuroblastoma by targeting CTGF and PDGF-β.
Wang M; Liu Y; Zou J; Yang R; Xuan F; Wang Y; Gao N; Cui H
Oncotarget; 2015 Apr; 6(11):9517-30. PubMed ID: 25940705
[TBL] [Abstract][Full Text] [Related]
62. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.
Konsavage WM; Kyler SL; Rennoll SA; Jin G; Yochum GS
J Biol Chem; 2012 Apr; 287(15):11730-9. PubMed ID: 22337891
[TBL] [Abstract][Full Text] [Related]
63. Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.
Ammoun S; Provenzano L; Zhou L; Barczyk M; Evans K; Hilton DA; Hafizi S; Hanemann CO
Oncogene; 2014 Jan; 33(3):336-46. PubMed ID: 23318455
[TBL] [Abstract][Full Text] [Related]
64. TAZ promotes epithelial to mesenchymal transition via the upregulation of connective tissue growth factor expression in neuroblastoma cells.
Wang Q; Xu Z; An Q; Jiang D; Wang L; Liang B; Li Z
Mol Med Rep; 2015 Feb; 11(2):982-8. PubMed ID: 25354978
[TBL] [Abstract][Full Text] [Related]
65. Protein kinase C α is involved in the regulation of AXL receptor tyrosine kinase expression in triple-negative breast cancer cells.
Yue CH; Liu LC; Kao ES; Lin H; Hsu LS; Hsu CW; Lin YY; Lin YS; Liu JY; Lee CJ
Mol Med Rep; 2016 Aug; 14(2):1636-42. PubMed ID: 27357025
[TBL] [Abstract][Full Text] [Related]
66. Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma.
Han SX; Bai E; Jin GH; He CC; Guo XJ; Wang LJ; Li M; Ying X; Zhu Q
J Immunol Res; 2014; 2014():261365. PubMed ID: 24860833
[TBL] [Abstract][Full Text] [Related]
67. TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase.
Wang X; Saso H; Iwamoto T; Xia W; Gong Y; Pusztai L; Woodward WA; Reuben JM; Warner SL; Bearss DJ; Hortobagyi GN; Hung MC; Ueno NT
Cancer Res; 2013 Nov; 73(21):6516-25. PubMed ID: 24014597
[TBL] [Abstract][Full Text] [Related]
68. YAP and TAZ are distinct effectors of corneal myofibroblast transformation.
Muppala S; Raghunathan VK; Jalilian I; Thomasy S; Murphy CJ
Exp Eye Res; 2019 Mar; 180():102-109. PubMed ID: 30578787
[TBL] [Abstract][Full Text] [Related]
69. Molecular markers of endometrial epithelial cell mitogenesis mediated by the Sp/Krüppel-like factor BTEB1.
Simmen RC; Zhang XL; Michel FJ; Min SH; Zhao G; Simmen FA
DNA Cell Biol; 2002 Feb; 21(2):115-28. PubMed ID: 11953011
[TBL] [Abstract][Full Text] [Related]
70. Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma.
Bouvier C; Macagno N; Nguyen Q; Loundou A; Jiguet-Jiglaire C; Gentet JC; Jouve JL; Rochwerger A; Mattei JC; Bouvard D; Salas S
Oncotarget; 2016 Oct; 7(40):64702-64710. PubMed ID: 27608849
[TBL] [Abstract][Full Text] [Related]
71. Expression and prognostic significance of YAP, TAZ, TEAD4 and p73 in human laryngeal cancer.
Tsinias G; Nikou S; Mastronikolis N; Bravou V; Papadaki H
Histol Histopathol; 2020 Sep; 35(9):983-995. PubMed ID: 32378727
[TBL] [Abstract][Full Text] [Related]
72. Bufalin down-regulates Axl expression to inhibit cell proliferation and induce apoptosis in non-small-cell lung cancer cells.
Kim NY; Suh YA; Kim S; Lee C
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32219334
[TBL] [Abstract][Full Text] [Related]
73. Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer.
Linger RM; Cohen RA; Cummings CT; Sather S; Migdall-Wilson J; Middleton DH; Lu X; Barón AE; Franklin WA; Merrick DT; Jedlicka P; DeRyckere D; Heasley LE; Graham DK
Oncogene; 2013 Jul; 32(29):3420-31. PubMed ID: 22890323
[TBL] [Abstract][Full Text] [Related]
74. Microarray and pattern miner analysis of AXL and VIM gene networks in MDA‑MB‑231 cells.
Natarajan S; Sumantran VN; Ranganathan M; Madheswaran S
Mol Med Rep; 2018 Oct; 18(4):4147-4155. PubMed ID: 30132537
[TBL] [Abstract][Full Text] [Related]
75. Neuromedin U contributes to radiation resistance in colorectal cancer via YAP/TAZ signaling activation.
Sim MK; Park JE; Kim SR; Lee J; Kim EJ; Kim Y; Shin US; Kim H; Kim KS
Oncol Rep; 2023 Oct; 50(4):. PubMed ID: 37594135
[TBL] [Abstract][Full Text] [Related]
76. SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis.
Lamar JM; Xiao Y; Norton E; Jiang ZG; Gerhard GM; Kooner S; Warren JSA; Hynes RO
J Biol Chem; 2019 Feb; 294(7):2302-2317. PubMed ID: 30559289
[TBL] [Abstract][Full Text] [Related]
77. RASSF1A-Hippo pathway link in patients with urothelial carcinoma of bladder: plausible therapeutic target.
Khandelwal M; Anand V; Appunni S; Seth A; Singh P; Mathur S; Sharma A
Mol Cell Biochem; 2020 Jan; 464(1-2):51-63. PubMed ID: 31754973
[TBL] [Abstract][Full Text] [Related]
78. Regulation of the Receptor Tyrosine Kinase AXL in Response to Therapy and Its Role in Therapy Resistance in Glioblastoma.
Scherschinski L; Prem M; Kremenetskaia I; Tinhofer I; Vajkoczy P; Karbe AG; Onken JS
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055167
[TBL] [Abstract][Full Text] [Related]
79. Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma.
Lamhamedi-Cherradi SE; Mohiuddin S; Mishra DK; Krishnan S; Velasco AR; Vetter AM; Pence K; McCall D; Truong DD; Cuglievan B; Menegaz BA; Utama B; Daw NC; Molina ER; Zielinski RJ; Livingston JA; Gorlick R; Mikos AG; Kim MP; Ludwig JA
Cancer Gene Ther; 2021 Dec; 28(12):1325-1338. PubMed ID: 33408328
[TBL] [Abstract][Full Text] [Related]
80. New twists in the AXL(e) of tumor progression.
Halmos B; Haura EB
Sci Signal; 2016 Oct; 9(448):fs14. PubMed ID: 27703029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
